BR112013008701A2 - biomarcadores para doença cardíaca valvular - Google Patents

biomarcadores para doença cardíaca valvular

Info

Publication number
BR112013008701A2
BR112013008701A2 BR112013008701A BR112013008701A BR112013008701A2 BR 112013008701 A2 BR112013008701 A2 BR 112013008701A2 BR 112013008701 A BR112013008701 A BR 112013008701A BR 112013008701 A BR112013008701 A BR 112013008701A BR 112013008701 A2 BR112013008701 A2 BR 112013008701A2
Authority
BR
Brazil
Prior art keywords
biomarkers
heart disease
valvular heart
valvular
disease
Prior art date
Application number
BR112013008701A
Other languages
English (en)
Other versions
BR112013008701B1 (pt
Inventor
Arun Bandyopadhyay
Santanu Dutta
Somaditya Mukherjee
Tanima Banerjee
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Publication of BR112013008701A2 publication Critical patent/BR112013008701A2/pt
Publication of BR112013008701B1 publication Critical patent/BR112013008701B1/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BR112013008701-3A 2010-10-13 2011-10-13 Método de detecção da presença de doença cardíaca valvular de origem reumática em um indivíduo BR112013008701B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2440DE2010 2010-10-13
IN2440/DEL/2010 2010-10-13
PCT/IB2011/002400 WO2012049560A1 (en) 2010-10-13 2011-10-13 Biomarker for valvular heart disease

Publications (2)

Publication Number Publication Date
BR112013008701A2 true BR112013008701A2 (pt) 2016-06-21
BR112013008701B1 BR112013008701B1 (pt) 2021-08-03

Family

ID=44993621

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013008701-3A BR112013008701B1 (pt) 2010-10-13 2011-10-13 Método de detecção da presença de doença cardíaca valvular de origem reumática em um indivíduo

Country Status (4)

Country Link
AP (1) AP2013006853A0 (pt)
BR (1) BR112013008701B1 (pt)
WO (1) WO2012049560A1 (pt)
ZA (1) ZA201302538B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101787485B1 (ko) * 2015-12-30 2017-11-15 재단법인 의약바이오컨버젼스연구단 재조합 picp 단백질 및 이에 특이적으로 결합하는 항체의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1483399B1 (en) * 2002-02-12 2008-10-29 The Regents of the University of California Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products
US9012160B2 (en) * 2008-06-16 2015-04-21 Abraham Amir Monitoring skin metabolism products for evaluating burn injury

Also Published As

Publication number Publication date
ZA201302538B (en) 2015-08-26
AP2013006853A0 (en) 2013-05-31
BR112013008701B1 (pt) 2021-08-03
WO2012049560A1 (en) 2012-04-19

Similar Documents

Publication Publication Date Title
IL222232A0 (en) Circulating biomarkers for disease
EP2606353A4 (en) CIRCULATING BIOMARKERS FOR DISEASE
BR112012025075A2 (pt) imunuensaio para vitamina d livre
BR112013010441A2 (pt) doença inflamatória
FR2963703B1 (fr) Hvpmos renforce
BRPI1013082A2 (pt) marcadores de risco para enfermidade cardiovascular
DK2574309T3 (da) Bøjningsstiv acetabularskål
BRPI1014262A2 (pt) anticorpos específicos para caderina-17
DK3202789T3 (da) Anti-vla-4-antistoffer
DK2598525T3 (da) Frataxin-mutanter
BR112013031218A2 (pt) protetores solares
BR112013015601A2 (pt) método para produzir 2-(triazinilcarbonil) sulfonanilidas
ES1072252Y (es) Bandeja para lavaplatos
BR112013031107A2 (pt) protetores solares
BR112013008701A2 (pt) biomarcadores para doença cardíaca valvular
ES1074173Y (es) Pieza para solados
BR112013031217A2 (pt) protetores solares
BR112013031538A2 (pt) protetores solares
ES1070148Y (es) Macolla para barrotes mejorada
ES1073433Y (es) Asiento para tareas pluriposturales
ES1073423Y (es) Mastil para banderola
DOP2011000313A (es) Anticuerpos especificos para caderin-17
ES1070663Y (es) Cenicero exclusivo para c0lillas
ES1073282Y (es) Estuche para bocadillos
ES1071124Y (es) Parapente para aeromodelismo

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/10/2011, OBSERVADAS AS CONDICOES LEGAIS.